EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

New generation of rabies vaccine. Vaccinia-rabies glycoprotein recombinant virus


Applied Virology Research, Volume 1 New Vaccines and Chemotherapy: 69-90
New generation of rabies vaccine. Vaccinia-rabies glycoprotein recombinant virus
After a description of rabies virus structures and vaccinia virus, construction of a vaccinia rabies glycoprotein recombinant virus is described. Results summarized from several experiments indicate that the vaccinia-rabies glycoprotein recombinant virus was highly immunogenic and gave better protection rates that conventional rabies vaccines.


Accession: 001893744



Related references

Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals. Vaccine 22(25/26): 3329-3333, 2004

Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals. Vaccine 22(25-26): 3329-3333, 2004

Rabies virus glycoprotein expressed in a vaccinia virus recombinant vaccine cross protects mice against unique genetic variants of rabies viruses isolated worldwide. Journal of Cellular Biochemistry Supplement 0(19A): 312, 1995

Development of an oral wildlife rabies vaccine immunization of raccoons by a vaccinia rabies glycoprotein recombinant virus and preliminary field baiting trials. Chanock, R M , Et Al (Ed ) Vaccines, 87 Modern Approaches to New Vaccines: Prevention Of Aids And Other Viral, Bacterial, And Parasitic Diseases; Conference, Cold Spring Harbor, New York, Usa, 1986 Xxiii+461p Cold Spring Harbor Laboratory: Cold Spring Harbor, New York, Usa Illus Paper 389-392, 1987

Efficacy of an oral vaccinia-rabies glycoprotein recombinant vaccine in controlling epidemic raccoon rabies in New Jersey. Journal of Wildlife Diseases 34(4): 752-763, 1998

Development of a vaccinia-rabies glycoprotein recombinant virus vaccine. Rabies : 335-364, 1988

Immunization of foxes against rabies with a vaccinia recombinant virus expressing the rabies glycoprotein. Archives of Virology 102(3-4): 297-301, 1988

Towards rabies elimination in Belgium by fox vaccination using a vaccinia-rabies glycoprotein recombinant virus. Vaccine 12(15): 1368-1371, 1994

Immunization against rabies using a vaccinia-rabies recombinant virus expressing the surface glycoprotein. Vaccines 85: molecular and chemical basis of resistance to parasitic bacterial and viral diseases edited by Richard A Lerner Robert M Chanock Fred Brown: 162, 1985

Immunization against rabies using a recombinant vaccinia virus expressing the rabies glycoprotein. Genetical Research 45(2): 213, 1985